Colman Adolfo L MD - 33470 Loxahatchee, FL

Business Name: Colman Adolfo L MD
Categorized In: Doctors
Address: 12953 Palms West Drive # 201, Loxahatchee, FL 33470
Phone Number: (561) 790-2111
Contact Person: Adolfo Colman
Website Address: palmbeachurology.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Jeffrey Kuger L Md - Loxahatchee, FL 33470
Dehghanpisheh Keivan MD - Loxahatchee, FL 33470
Urology Center of Palm Beach - Loxahatchee, FL 33470
Cerullo James A MD - Loxahatchee, FL 33470
Suklenik LA MD - Loxahatchee, FL 33470
Pajo Silao Bebe MD - Loxahatchee, FL 33470
Toller Erin C DO - Loxahatchee, FL 33470
Kurland Sima S DO - Loxahatchee, FL 33470
Pillitteri Rian J MD - Loxahatchee, FL 33470
Doan Bao-Tran MD - Loxahatchee, FL 33470
Napoles-Ruiz Ana Maria MD - Loxahatchee, FL 33470
Bequer Napoleon G MD - Loxahatchee, FL 33470
Konda Prasad MD - Loxahatchee, FL 33470
Srivastava Monika MD - Loxahatchee, FL 33470
Goad James J MD - Loxahatchee, FL 33470
Liu Edwin MD - Loxahatchee, FL 33470
South FL Neurosurgical - Loxahatchee, FL 33470
Palm Beach Ped Hmtlgy/Oncology - Loxahatchee, FL 33470
Melissa S Singer MD MPH FAAP - Loxahatchee, FL 33470
Cheryl Wayne, MD - Loxahatchee, FL 33470

Colman Adolfo L MD provides professional Doctors from its single location at the coordinates 26.68313,-80.25002.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 12953 Palms West Drive # 201, Loxahatchee, Florida 33470 or contacted through representative Adolfo Colman at (561) 790-2111.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Colman Adolfo L MD through its company website at palmbeachurology.com. Engage with this business on its social media platforms through on Twitter and on Facebook.